Therapeutic failure in moderate and severe psoriasis patients in a health institution - a transversal study of prevalence and demographic determinants.
Daniel Montoya-LondoñoCarlos Alberto Gómez-MercadoJorge Iván Estrada-AcevedoJuliana Madrigal-CadavidAngela María Segura-CardonaNewar Andrés Giraldo-AlzateAngela Londoño GarcíaPublished in: The Journal of dermatological treatment (2022)
Being male and receiving biologic therapy are associated with a higher incidence of therapeutic failure in the treatment of moderate or severe psoriasis. The increase in DLQI increase in the probability of failure, and mayor age or days of treatment decrease in the probability of failure.
Keyphrases
- end stage renal disease
- healthcare
- risk factors
- public health
- rheumatoid arthritis
- ejection fraction
- early onset
- high intensity
- newly diagnosed
- peritoneal dialysis
- mental health
- risk assessment
- mesenchymal stem cells
- climate change
- atopic dermatitis
- patient reported outcomes
- health information
- human health
- health promotion